We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EBMT:NASDAQEagle Bancorp Montana, Inc. Analysis

Data as of 2026-09-01 - not real-time

$22.29

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Eagle Bancorp Montana, Inc. is priced at $22.29, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 4.6%. RSI sits at 36.6, which reads as approaching oversold, and MACD momentum is bearish. Price has been bracketed by support at $21.87 and resistance at $24.05.
The shares look undervalued, trading on 10.9 times earnings below a sector average of 16.7. The average analyst target implies 12.2% above today's level. Revenue is growing at 8.7% on a 17.0% profit margin. The 2.60% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 19.5%, a beta of 0.26 and a maximum drawdown of 13.9%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination...Montana's Eagle Bancorp beat revenue expectations by 27% on expanding net interest margins, though EPS fell short as...HELENA, Mont., July 28, 2026 GLOBE NEWSWIRE -- Eagle Bancorp Montana, Inc. NASDAQ: EBMT , the “Company,”...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 21.56
  • MACD momentum is negative
  • RSI at 36.6 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.9 versus sector average of 16.7
  • Trading above the 200-day average of 21.56
  • Analyst targets imply +12.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 10.9 versus sector average of 16.7
  • Analyst targets imply +12.2% versus the current price
  • Profit margin of 17.0% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin16.95%
P/E Ratio10.9
ROE8.49%
ROA0.75%
P/B Ratio0.9
Op. Cash Flow$22.7M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI36.6
Support$21.87
Resistance$24.05
MA 20$23.13
MA 50$23.37
MA 200$21.56
MACDBearish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Fair Value$28.07
Target Price$25.00
Upside/Downside12.16%
GradeUndervalued
TypeValue
Dividend Yield2.60%

Risk Assessment

Beta0.26
Volatility19.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.